PBMT Conference 2025 – Practice Changing Updates in Hematology
📍 Pearl Continental, Rawalpindi | 7–9 November 2025
Al Habib Pharmaceuticals proudly participated in the PBMT Conference 2025, a prestigious scientific forum that brought together leading hematologists, oncologists, transplant physicians, and global experts. The conference served as a powerful platform for knowledge exchange, clinical discussions, and collaboration aimed at advancing standards of blood cancer care in Pakistan.
Our team actively engaged with clinicians and faculty members, sharing insights on therapeutic innovations and strengthening professional partnerships aligned with our commitment to the Nation’s Health.
Advancing Oncology Through Scientific Dialogue
đź“Ť INMOL Hospital, Lahore
Al Habib Pharmaceuticals successfully conducted a scientific presentation on SIMBIOTE® (Bortezomib) at INMOL Hospital, Lahore. The session was held within an academic and evidence-based environment, fostering meaningful scientific exchange in oncology care.
The discussion focused on disease understanding, diagnostic considerations, and practical clinical insights in multiple myeloma, providing valuable perspectives for day-to-day oncology practice.
Presenter: Dr. Ahmad Farooq
Participants: Oncology consultants and postgraduate residents,
INMOL Hospital, Lahore
This engagement reflects our continued commitment to science-led education, responsible communication, and meaningful clinical exchange in oncology care.
Best of ASCO 2025 – Pakistan Annual Meeting
đź“Ť Pakistan | Organized by Society of Medical Oncology Pakistan (SMOP)
Over three dynamic days at the Best of ASCO 2025 – Pakistan Annual Meeting, organized by the Society of Medical Oncology Pakistan (SMOP), the Al Habib Pharmaceuticals stall served as a focal point for meaningful dialogue and professional engagement within the oncology community.
Experts from leading institutions shared insights on cutting-edge developments in oncology, including immunotherapy, precision medicine, artificial intelligence–driven innovations, and public–private partnerships shaping the future of cancer care.
These scientific exchanges reaffirm our commitment to supporting oncology professionals and contributing to improved patient outcomes across Pakistan through responsible engagement and knowledge sharing.
AHP EMTA (Pemetrexed 500mg) – Product Launch Ceremony
đź“Ť NORIN Hospital, Nawabshah
Al Habib Pharmaceuticals proudly announced the introduction of Pemetrexed 500mg Injection (AHP EMTA) as the first European-source Pemetrexed available in Pakistan’s oncology market. This milestone reflects our commitment to providing high-quality oncology therapies that meet international standards while addressing local patient needs.
The launch ceremony of AHP EMTA was held at NORIN Hospital, Nawabshah, where healthcare professionals gathered to mark this important step toward expanding access to reliable and effective oncology treatment options.
At Al Habib Pharmaceuticals, our mission remains focused on enhancing patients’ quality of life by delivering safe, high-standard products supported by responsible scientific engagement and ethical marketing practices.
HaemCon 2025 – Day 2 Highlights
đź“Ť Pakistan Society of Haematology Annual Conference, Karachi
On Day 2 of HaemCon 2025, organized by the Pakistan Society of Haematology, the Al Habib Pharmaceuticals stall continued to serve as an active platform for professional dialogue and engagement with the haematology and oncology community.
Our team had the opportunity to interact with leading consultants, specialists, and partners from renowned institutions including INMOL Hospital and Shaukat Khanum Memorial Cancer Hospital. These interactions reflected a shared commitment toward advancing care in haematology and oncology through collaboration and scientific exchange.
The day concluded with a team interaction alongside company leadership, including CEO Mr. Azeem Ullah Khan and Managing Director Mr. Abdullah Khan, reaffirming our mission of being Determined to the Nation’s Health.
This engagement highlights Al Habib Pharmaceuticals’ continued focus on supporting healthcare professionals and strengthening oncology and haematology care across Pakistan.
